| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―May―11 |
Care options for individuals affected by SARS-CoV-2 infection |
I Lochman, V Thon, J Kratochvíla |
| 2 |
[GO] |
2025―May―11 |
MxA protein and its application in early diagnosis of viral infections including SARS-CoV-2 |
M Šrámková, P Lehnert, R Průša |
| 3 |
[GO] |
2025―May―11 |
Serum biochemical analytes, COVID-19 and harmonization |
B Friedecký, J Kratochvíla |
| 4 |
[GO] |
2025―May―11 |
The use of microRNA biomarkers by the TT-PCR method for the diagnosis of COVID-19 |
D Štěpán, P Kušnierová |
| 5 |
[GO] |
2025―May―10 |
Comparison of two analytical methods for SARS-CoV-2 determination, RT-PCR vs. reverse transcription and loop-mediated isothermal amplification (RT-LAMP) |
P Kušnierová, D Stejskal, Z Švagera, H Slepčanová, M Malurová, Z Špulerová, et al. (+4) K Matějová, R Kozelská, O Michnová, Z Čermáková |
| 6 |
[GO] |
2025―May―10 |
New coronavirus 2019. Some basic information and their availability |
B Friedecký |
| 7 |
[GO] |
2025―May―10 |
COVID-19 from the view of free radicals and antioxidants |
V Holeček |
| 8 |
[GO] |
2025―May―10 |
Laboratory aspects of COVID-19. Diagnosis, epidemiology, prognosis of patients |
B Friedecký, J Kratochvíla |
| 9 |
[GO] |
2025―May―10 |
How do the results of biochemical, hematological, coagulation and inflammatory markers in COVID-19 change? |
B Friedecký |
| 10 |
[GO] |
2025―May―10 |
Antibodies against SARS-CoV-2. Use in convalescence of patients after COVID-19 and after vaccination |
B Friedecký |
| 11 |
[GO] |
2025―May―10 |
Laboratory diagnostics of COVID-19 |
I Lochman, J Kratochvíla, B Friedecký |
| 12 |
[GO] |
2025―May―10 |
Analytes of clinical biochemistry and hematology in COVID-19 |
B Friedecký, J Kratochvíla |
